title: DNA polymorphisms in linkage disequilibrium at the 3' end of the human APO AII gene: relationships with lipids, apolipoproteins and coronary heart disease.
abstract: Two investigations were undertaken to analyze the 3' region of the apolipoprotein AII (Apo AII) gene in patients with myocardial infarction (MI) and controls. Previous studies have suggested that a MspI polymorphism in this gene may be associated with hypertriglyceridaemia, high levels of HDL cholesterol and Apo AII. To verify this hypothesis, the distribution of MspI genotypes and their possible associations with several plasma lipid variables were studied in 882 subjects (411 cases with MI and 471 controls) from the ECTIM study. There were no differences in genotype and allele frequencies between cases and controls, and no differences in lipid variable levels in controls carrying the less frequent MspI allele vs other controls. Using single-strand conformation polymorphism (SSCP) analysis, we detected a new polymorphism which caused by a C-to-T transition located in the third intron near the splice junction site (acceptor). This polymorphism modifies a Bst N1 restriction site. The ECTIM population was screened for this new marker, and no significant associations with MI and plasma lipid levels were found. Our results suggest that these two variants located in the coding region of the Apo AII gene are unlikely to contribute significantly to the level of plasma lipid variables and the risk of coronary heart disease (CHD) in the European population.
authors.affiliation: Laboratoire de Biochimie A, Institut de Biologie, Montpellier, France.
authors.forename: A M
authors.initials: AM
authors.lastname: Dupuy-Gorce
authors.forename: E
authors.initials: E
authors.lastname: Desmarais
authors.forename: S
authors.initials: S
authors.lastname: Vigneron
authors.forename: C
authors.initials: C
authors.lastname: Buresi
authors.forename: V
authors.initials: V
authors.lastname: Nicaud
authors.forename: A
authors.initials: A
authors.lastname: Evans
authors.forename: G
authors.initials: G
authors.lastname: Luc
authors.forename: D
authors.initials: D
authors.lastname: Arveiler
authors.forename: P
authors.initials: P
authors.lastname: Marqués-Vidal
authors.forename: F
authors.initials: F
authors.lastname: Cambien
authors.forename: L
authors.initials: L
authors.lastname: Tiret
authors.forename: A
authors.initials: A
authors.lastname: Crastes de Paulet
authors.forename: G
authors.initials: G
authors.lastname: Roizés
mesh_terms: D000328:Adult; D016633:Apolipoprotein A-II / Q000097:blood / Q000235:genetics*; D001053:Apolipoproteins / Q000097:blood; D004252:DNA Mutational Analysis; D005787:Gene Frequency; D005819:Genetic Markers; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000235:genetics*; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D018807:Polymorphism, Single-Stranded Conformational
chemical_list: D016633:Apolipoprotein A-II; D001053:Apolipoproteins; D005819:Genetic Markers; D008055:Lipids